Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3951)
All Articles published online
|
Publishing Process of This Article
|
Dec 6, 2023 (publication date) through Jul 5, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yuan GC, Chen AZ, Wang WX, Yi XL, Tu L, Peng F, Qiu ZH. Efficacy and safety of tenofovir alafenamide in patients with chronic hepatitis B exhibiting suboptimal response to entecavir. World J Clin Cases 2023; 11(34): 8139-8146 [PMID: 38130795 DOI: 10.12998/wjcc.v11.i34.8139] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v11/i34/8139.htm |
| Number | Citing Articles |
| 1 |
Jian-Xing Luo, Guo Chen, Xiao-Yu Hu, Chang Yu. Tenofovir alafenamide versus entecavir in treating patients with chronic hepatitis B: A meta-analysis. Gastroenterología y Hepatología (English Edition) 2025; 48(4): 502276 doi: 10.1016/j.gastre.2025.502276
|
| 2 |
Liang Wang, Shipeng Ma, Lajpat Rai Malhi, Xiaoping Wu, Liping Liu, Xin Wan, Yuliang Zhang, Xiaopeng Li, Shanfei Ge. Improvement in renal function after switching from entecavir to tenofovir alafenamide in chronic hepatitis B patients with low estimated glomerular filtration rates. Annals of Hepatology 2025; 30(2): 101925 doi: 10.1016/j.aohep.2025.101925
|
| 3 |
Yongzheng Hu, Yue Zhang, Wei Jiang. Targeting hepatitis B virus-associated nephropathy: efficacy and challenges of current antiviral treatments. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01584-4
|
| 4 |
Jian-Xing Luo, Guo Chen, Xiao-Yu Hu, Chang Yu. Tenofovir alafenamide versus entecavir in treating patients with chronic hepatitis B: A meta-analysis. Gastroenterología y Hepatología 2025; 48(4): 502276 doi: 10.1016/j.gastrohep.2024.502276
|
| 5 |
Yu-Xuan Song, Guang-Jun Song, Hui Ma, Bo Feng, Yan-Di Xie. Long-Term Real-World Outcomes of Tenofovir Alafenamide in Chronic Hepatitis B: Detailed Analysis of Treatment-Naive and Experienced Patients. The Korean Journal of Gastroenterology 2025; 85(1): 64 doi: 10.4166/kjg.2024.140
|